4.6 Article Proceedings Paper

Outcomes of acute coronary syndrome in a large Canadian cohort: Impact of chronic renal insufficiency, cardiac interventions, and anemia

期刊

AMERICAN JOURNAL OF KIDNEY DISEASES
卷 46, 期 5, 页码 845-855

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2005.07.043

关键词

renal function; survival analysis; cardiovascular; epidemiology; prognosis

向作者/读者索取更多资源

Background Chronic renal insufficiency (CRI) has been identified as an important risk factor for cardiac events. Studies in the United States reported decreased survival and decreased use of surgical and medical interventions after myocardial infarction in patients with CRI. Methods: We studied the impact of renal function on health outcomes in a Canadian cohort of consecutive patients admitted with acute coronary syndrome (ACS) between October 1997 and October 1999. The study design is an observational cohort of 5,549 adult patients who survived to discharge with a discharge diagnosis of ACS. Renal function is classified into 4 levels: (1) normal, glomerular filtration rate (GFR) greater than 80 mL/min/1.73 m(2) (>1.33 mL/s); (2) mild CRl, GFR of 60 to 80 mL/min/1.73 m(2) (1.00 to 1.33 mL/s); (3) moderate CRl, GFR of 30 to 59 mL/min/1.73 m(2) (0.50 to 0.98 mL/s); and (4) severe CRl, GFR less than 30 mL/min/1.73 m(2) (<0.50 mL/s). The primary outcome is death. Results: Advanced and moderate CRl independently predicted death (hazard ratio, 1.06; 95% confidence interval [CI], 1.01 to 1.12; and hazard ratio, 1.23; 95% Cl, 1.18 to 1.29). Severe anemia (hemoglobin level < 9.0 g/dL [<90 g/L]) also was an independent risk factor for death (hazard ratio, 1.38; 95% Cl, 1.18 to 1.61). Use of beta-blockers (hazard ratio, 0.91; 95% Cl, 0.86 to 0.97), acetylsalicylic acid (hazard ratio, 0.90; 95% Cl, 0.84 to 0.97), lipid-lowering therapy (hazard ratio, 0.84; 95% Cl, 0.78 to 0.89), and medical thrombolysis (hazard ratio, 0.89; 95% Cl, 0.81 to 0.97) were associated with reduced risk for death. Medical interventions with beta-blockers, acetylsalicylic acid, lipid-lowering therapy, and thrombolysis and surgical intervention were significantly less likely to be used in patients with CRI. Conclusion: Despite universal access to health care, Canadian patients with CRI are more likely to die after a cardiac event and less likely to receive important interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据